Adamis Pharmaceuticals Ownership 2024 | Who Owns Adamis Pharmaceuticals Now?
Institutional Ownership
18.04%
Insider Ownership
7.81%
Retail Ownership
74.15%
Institutional Holders
47.00
Adamis Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | - | - | - | -25,742 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -11,037 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -244,634 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -475,373 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -6,483,945 | -100.00% | - | Jun 30, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -12,860 | -100.00% | - | Jun 30, 2023 |
| OPPENHEIMER & CO INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -114,218 | -100.00% | - | Jun 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -5,609 | -100.00% | - | Jun 30, 2023 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -16,635 | -100.00% | - | Jun 30, 2023 |
| HOLLENCREST CAPITAL MANAGEMENT | - | - | - | -2,000 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,326,654 | -100.00% | - | Jun 30, 2023 |
| REGIONS FINANCIAL CORP | - | - | - | -34,500 | -100.00% | - | Jun 30, 2023 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -2,766,939 | -100.00% | - | Jun 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -84,002 | -100.00% | - | Jun 30, 2023 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -69,699 | -100.00% | - | Jun 30, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -327,168 | -100.00% | - | Jun 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -24,628 | -100.00% | - | Jun 30, 2023 |
| SIGNATUREFD, LLC | - | - | - | -863 | -100.00% | - | Jun 30, 2023 |
Adamis Pharmaceuticals's largest institutional shareholder is BANK OF AMERICA CORP /DE/, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | - | - | - | -25,742 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -11,037 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -244,634 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -475,373 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -6,483,945 | -100.00% | - | Jun 30, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -12,860 | -100.00% | - | Jun 30, 2023 |
| OPPENHEIMER & CO INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -114,218 | -100.00% | - | Jun 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -5,609 | -100.00% | - | Jun 30, 2023 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -16,635 | -100.00% | - | Jun 30, 2023 |
| HOLLENCREST CAPITAL MANAGEMENT | - | - | - | -2,000 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,326,654 | -100.00% | - | Jun 30, 2023 |
| REGIONS FINANCIAL CORP | - | - | - | -34,500 | -100.00% | - | Jun 30, 2023 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -2,766,939 | -100.00% | - | Jun 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -84,002 | -100.00% | - | Jun 30, 2023 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -69,699 | -100.00% | - | Jun 30, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -327,168 | -100.00% | - | Jun 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -24,628 | -100.00% | - | Jun 30, 2023 |
| SIGNATUREFD, LLC | - | - | - | -863 | -100.00% | - | Jun 30, 2023 |
The largest Adamis Pharmaceuticals shareholder by % of total assets is BANK OF AMERICA CORP /DE/. The company owns 0.00 shares of Adamis Pharmaceuticals (ADMP), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -7 | -100.00% | - | Jun 30, 2023 |
| SIGNATUREFD, LLC | - | - | - | -863 | -100.00% | - | Jun 30, 2023 |
| BELPOINTE ASSET MANAGEMENT LLC | - | - | - | -900 | -100.00% | - | Jun 30, 2023 |
| HOLLENCREST CAPITAL MANAGEMENT | - | - | - | -2,000 | -100.00% | - | Jun 30, 2023 |
| NEWEDGE ADVISORS, LLC | - | - | - | -2,700 | -100.00% | - | Jun 30, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -3,530 | -100.00% | - | Jun 30, 2023 |
| FOUNDERS CAPITAL MANAGEMENT | - | - | - | -5,000 | -100.00% | - | Jun 30, 2023 |
| TIMESCALE FINANCIAL, INC. | - | - | - | -5,100 | -100.00% | - | Jun 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -5,609 | -100.00% | - | Jun 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -6,191 | -100.00% | - | Jun 30, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -8,930 | -100.00% | - | Jun 30, 2023 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
| MGO ONE SEVEN LLC | - | - | - | -10,615 | -100.00% | - | Jun 30, 2023 |
| WOLFF WIESE MAGANA LLC | - | - | - | -10,740 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -11,037 | -100.00% | - | Jun 30, 2023 |
| OPPENHEIMER & CO INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -12,860 | -100.00% | - | Jun 30, 2023 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -16,635 | -100.00% | - | Jun 30, 2023 |
| RVW WEALTH, LLC | - | - | - | -19,000 | -100.00% | - | Jun 30, 2023 |
| B. RILEY WEALTH ADVISORS, INC. | - | - | - | -20,000 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Adamis Pharmaceuticals's largest institutional buyer is FNY INVESTMENT ADVISERS, LLC. The company purchased -7.00 stocks of ADMP, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | - | - | - | -14,500,000 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -6,483,945 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -2,766,939 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,326,654 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -475,373 | -100.00% | - | Jun 30, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -327,168 | -100.00% | - | Jun 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -268,781 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -244,634 | -100.00% | - | Jun 30, 2023 |
| HRT FINANCIAL LP | - | - | - | -143,859 | -100.00% | - | Jun 30, 2023 |
| UBS GROUP AG | - | - | - | -128,202 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -114,218 | -100.00% | - | Jun 30, 2023 |
| EDMOND DE ROTHSCHILD HOLDING S.A. | - | - | - | -100,000 | -100.00% | - | Jun 30, 2023 |
| CAPITAL CS GROUP, LLC | - | - | - | -94,103 | -100.00% | - | Jun 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -84,002 | -100.00% | - | Jun 30, 2023 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -69,699 | -100.00% | - | Jun 30, 2023 |
| VERDENCE CAPITAL ADVISORS LLC | - | - | - | -58,382 | -100.00% | - | Jun 30, 2023 |
| LIDO ADVISORS, LLC | - | - | - | -46,721 | -100.00% | - | Jun 30, 2023 |
| REGIONS FINANCIAL CORP | - | - | - | -34,500 | -100.00% | - | Jun 30, 2023 |
| AFFINITY CAPITAL ADVISORS, LLC | - | - | - | -30,315 | -100.00% | - | Jun 30, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -25,742 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Adamis Pharmaceuticals's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -14.50M shares of ADMP, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | - | - | - | -14,500,000 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -6,483,945 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -2,766,939 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -1,326,654 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -475,373 | -100.00% | - | Jun 30, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -327,168 | -100.00% | - | Jun 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -268,781 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -244,634 | -100.00% | - | Jun 30, 2023 |
| HRT FINANCIAL LP | - | - | - | -143,859 | -100.00% | - | Jun 30, 2023 |
| UBS GROUP AG | - | - | - | -128,202 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -114,218 | -100.00% | - | Jun 30, 2023 |
| EDMOND DE ROTHSCHILD HOLDING S.A. | - | - | - | -100,000 | -100.00% | - | Jun 30, 2023 |
| CAPITAL CS GROUP, LLC | - | - | - | -94,103 | -100.00% | - | Jun 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -84,002 | -100.00% | - | Jun 30, 2023 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -69,699 | -100.00% | - | Jun 30, 2023 |
| VERDENCE CAPITAL ADVISORS LLC | - | - | - | -58,382 | -100.00% | - | Jun 30, 2023 |
| LIDO ADVISORS, LLC | - | - | - | -46,721 | -100.00% | - | Jun 30, 2023 |
| REGIONS FINANCIAL CORP | - | - | - | -34,500 | -100.00% | - | Jun 30, 2023 |
| AFFINITY CAPITAL ADVISORS, LLC | - | - | - | -30,315 | -100.00% | - | Jun 30, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -25,742 | -100.00% | - | Jun 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -24,628 | -100.00% | - | Jun 30, 2023 |
| GLOBAL STRATEGIC INVESTMENT SOLUTIONS, LLC | - | - | - | -23,000 | -100.00% | - | Jun 30, 2023 |
| B. RILEY WEALTH ADVISORS, INC. | - | - | - | -20,000 | -100.00% | - | Jun 30, 2023 |
| RVW WEALTH, LLC | - | - | - | -19,000 | -100.00% | - | Jun 30, 2023 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -16,635 | -100.00% | - | Jun 30, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -12,860 | -100.00% | - | Jun 30, 2023 |
| OPPENHEIMER & CO INC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -11,037 | -100.00% | - | Jun 30, 2023 |
| WOLFF WIESE MAGANA LLC | - | - | - | -10,740 | -100.00% | - | Jun 30, 2023 |
| MGO ONE SEVEN LLC | - | - | - | -10,615 | -100.00% | - | Jun 30, 2023 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -8,930 | -100.00% | - | Jun 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -6,191 | -100.00% | - | Jun 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -5,609 | -100.00% | - | Jun 30, 2023 |
| TIMESCALE FINANCIAL, INC. | - | - | - | -5,100 | -100.00% | - | Jun 30, 2023 |
| FOUNDERS CAPITAL MANAGEMENT | - | - | - | -5,000 | -100.00% | - | Jun 30, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -3,530 | -100.00% | - | Jun 30, 2023 |
| NEWEDGE ADVISORS, LLC | - | - | - | -2,700 | -100.00% | - | Jun 30, 2023 |
| HOLLENCREST CAPITAL MANAGEMENT | - | - | - | -2,000 | -100.00% | - | Jun 30, 2023 |
| BELPOINTE ASSET MANAGEMENT LLC | - | - | - | -900 | -100.00% | - | Jun 30, 2023 |
| SIGNATUREFD, LLC | - | - | - | -863 | -100.00% | - | Jun 30, 2023 |
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -7 | -100.00% | - | Jun 30, 2023 |
Adamis Pharmaceuticals's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -14.50M shares, valued at -, as of undefined.
Adamis Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.21% | 109,800 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.07% | 209,602 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 6,202,363 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,238,492 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 114,367 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 16,872 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 56,257 | - | - | Feb 29, 2024 |
| ETF Managers Trust | 0.00% | 6,216 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 8,354 | - | - | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 2,905 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 9,187 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 16,635 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 14,319 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 55,379 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 3,008 | - | - | Mar 31, 2024 |
Adamis Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 109.80K shares, compromising 0.21% of its total assets.
Adamis Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 47 | -2.08% |
| 31 Dec, 22 | 48 | 14.29% |
| 30 Sep, 22 | 42 | -10.64% |
| 30 Jun, 22 | 47 | -4.08% |
| 31 Mar, 22 | 49 | -15.52% |
| 31 Dec, 21 | 58 | -3.33% |
| 30 Sep, 21 | 60 | 7.14% |
| 30 Jun, 21 | 56 | -5.08% |
| 31 Mar, 21 | 59 | 59.46% |
| 31 Dec, 20 | 37 | -19.57% |
| 30 Sep, 20 | 46 | 12.20% |
| 30 Jun, 20 | 41 | 2.50% |
| 31 Mar, 20 | 40 | 11.11% |
| 31 Dec, 19 | 36 | -21.74% |
| 30 Sep, 19 | 46 | -13.21% |
| 30 Jun, 19 | 53 | -10.17% |
| 31 Mar, 19 | 59 | -4.84% |
| 31 Dec, 18 | 62 | -1.59% |
| 30 Sep, 18 | 63 | 18.87% |
| 30 Jun, 18 | 53 | -8.62% |
| 31 Mar, 18 | 58 | -7.94% |
| 31 Dec, 17 | 63 | 21.15% |
| 30 Sep, 17 | 52 | -1.89% |
| 30 Jun, 17 | 53 | 51.43% |
| 31 Mar, 17 | 35 | -10.26% |
| 31 Dec, 16 | 39 | -7.14% |
| 30 Sep, 16 | 42 | 16.67% |
| 30 Jun, 16 | 36 | 24.14% |
| 31 Mar, 16 | 29 | 16.00% |
| 31 Dec, 15 | 25 | -3.85% |
| 30 Sep, 15 | 26 | -7.14% |
| 30 Jun, 15 | 28 | -3.45% |
| 31 Mar, 15 | 29 | 38.10% |
| 31 Dec, 14 | 21 | - |
| 30 Sep, 14 | 21 | 5.00% |
| 30 Jun, 14 | 20 | 5.26% |
| 31 Mar, 14 | 19 | 58.33% |
| 31 Dec, 13 | 12 | - |
As of 31 Mar 23, 47 institutions are holding Adamis Pharmaceuticals's shares, representing a decrease of -2.08% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 27,578,759 | 116.45% |
| 31 Dec, 22 | 12,741,373 | -0.87% |
| 30 Sep, 22 | 12,853,658 | -0.05% |
| 30 Jun, 22 | 12,860,150 | -0.47% |
| 31 Mar, 22 | 12,920,867 | -8.87% |
| 31 Dec, 21 | 14,178,275 | -5.86% |
| 30 Sep, 21 | 15,061,600 | -6.71% |
| 30 Jun, 21 | 16,144,910 | 28.66% |
| 31 Mar, 21 | 12,548,847 | 116.23% |
| 31 Dec, 20 | 5,803,579 | -12.40% |
| 30 Sep, 20 | 6,624,974 | 30.40% |
| 30 Jun, 20 | 5,080,368 | -37.72% |
| 31 Mar, 20 | 8,157,536 | 69.79% |
| 31 Dec, 19 | 4,804,485 | -41.06% |
| 30 Sep, 19 | 8,150,866 | 9.39% |
| 30 Jun, 19 | 7,451,029 | -28.51% |
| 31 Mar, 19 | 10,422,782 | 25.22% |
| 31 Dec, 18 | 8,323,796 | -21.33% |
| 30 Sep, 18 | 10,580,850 | 166.97% |
| 30 Jun, 18 | 3,963,338 | 14.32% |
| 31 Mar, 18 | 3,467,010 | -16.84% |
| 31 Dec, 17 | 4,169,135 | -24.88% |
| 30 Sep, 17 | 5,549,795 | 74.42% |
| 30 Jun, 17 | 3,181,891 | 3.06% |
| 31 Mar, 17 | 3,087,536 | 9.53% |
| 31 Dec, 16 | 2,818,843 | -3.40% |
| 30 Sep, 16 | 2,918,058 | 43.75% |
| 30 Jun, 16 | 2,029,888 | -21.98% |
| 31 Mar, 16 | 2,601,772 | -5.64% |
| 31 Dec, 15 | 2,757,389 | -62.74% |
| 30 Sep, 15 | 7,400,974 | 184.20% |
| 30 Jun, 15 | 2,604,122 | 4.66% |
| 31 Mar, 15 | 2,488,134 | 30.09% |
| 31 Dec, 14 | 1,912,592 | 99.38% |
| 30 Sep, 14 | 959,284 | -18.36% |
| 30 Jun, 14 | 1,174,964 | -29.75% |
| 31 Mar, 14 | 1,672,478 | -17.31% |
| 31 Dec, 13 | 2,022,521 | - |
Adamis Pharmaceuticals (ADMP) has 27.58M shares outstanding as of 31 Mar 23, up 116.45% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 18.04% | 25.98% |
| 31 Dec, 22 | 8.33% | 11.79% |
| 30 Sep, 22 | 8.41% | 11.88% |
| 30 Jun, 22 | 8.41% | 11.78% |
| 31 Mar, 22 | 8.45% | 2.53% |
| 31 Dec, 21 | 18.28% | 4.85% |
| 30 Sep, 21 | 19.42% | 4.48% |
| 30 Jun, 21 | 20.81% | 7.95% |
| 31 Mar, 21 | 16.18% | 28.90% |
| 31 Dec, 20 | 7.48% | 10.26% |
| 30 Sep, 20 | 8.54% | 9.39% |
| 30 Jun, 20 | 9.54% | 4.07% |
| 31 Mar, 20 | 15.32% | 18.82% |
| 31 Dec, 19 | 9.02% | 3.85% |
| 30 Sep, 19 | 15.30% | 7.82% |
| 30 Jun, 19 | 13.99% | 3.65% |
| 31 Mar, 19 | 19.57% | 8.01% |
| 31 Dec, 18 | 15.63% | 3.96% |
| 30 Sep, 18 | 19.86% | 35.88% |
| 30 Jun, 18 | 7.44% | 17.56% |
| 31 Mar, 18 | 6.51% | 10.62% |
| 31 Dec, 17 | 7.83% | 7.21% |
| 30 Sep, 17 | 10.42% | 29.20% |
| 30 Jun, 17 | 5.97% | 17.78% |
| 31 Mar, 17 | 5.80% | 20.70% |
| 31 Dec, 16 | 5.29% | 17.63% |
| 30 Sep, 16 | 5.48% | 37.72% |
| 30 Jun, 16 | 3.81% | 15.97% |
| 31 Mar, 16 | 4.88% | 18.23% |
| 31 Dec, 15 | 5.18% | 2.68% |
| 30 Sep, 15 | 13.89% | 58.13% |
| 30 Jun, 15 | 4.89% | 22.40% |
| 31 Mar, 15 | 4.67% | 36.23% |
| 31 Dec, 14 | 3.59% | 110.71% |
| 30 Sep, 14 | 1.80% | 37.01% |
| 30 Jun, 14 | 2.21% | 22.37% |
| 31 Mar, 14 | 3.14% | 21.78% |
| 31 Dec, 13 | 3.80% | - |
As of 31 Mar 23, Adamis Pharmaceuticals is held by 18.04% institutional shareholders, representing a 25.98% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 14 | -26.32% |
| 31 Dec, 22 | 19 | 171.43% |
| 30 Sep, 22 | 7 | -46.15% |
| 30 Jun, 22 | 13 | 30.00% |
| 31 Mar, 22 | 10 | -52.38% |
| 31 Dec, 21 | 21 | -4.55% |
| 30 Sep, 21 | 22 | -24.14% |
| 30 Jun, 21 | 29 | -9.38% |
| 31 Mar, 21 | 32 | 128.57% |
| 31 Dec, 20 | 14 | -26.32% |
| 30 Sep, 20 | 19 | 26.67% |
| 30 Jun, 20 | 15 | -11.76% |
| 31 Mar, 20 | 17 | 21.43% |
| 31 Dec, 19 | 14 | -17.65% |
| 30 Sep, 19 | 17 | - |
| 30 Jun, 19 | 17 | -29.17% |
| 31 Mar, 19 | 24 | 33.33% |
| 31 Dec, 18 | 18 | -51.35% |
| 30 Sep, 18 | 37 | 117.65% |
| 30 Jun, 18 | 17 | -32.00% |
| 31 Mar, 18 | 25 | -30.56% |
| 31 Dec, 17 | 36 | 44.00% |
| 30 Sep, 17 | 25 | -30.56% |
| 30 Jun, 17 | 36 | 140.00% |
| 31 Mar, 17 | 15 | -16.67% |
| 31 Dec, 16 | 18 | -21.74% |
| 30 Sep, 16 | 23 | 27.78% |
| 30 Jun, 16 | 18 | 80.00% |
| 31 Mar, 16 | 10 | -9.09% |
| 31 Dec, 15 | 11 | 22.22% |
| 30 Sep, 15 | 9 | -35.71% |
| 30 Jun, 15 | 14 | -22.22% |
| 31 Mar, 15 | 18 | 50.00% |
| 31 Dec, 14 | 12 | 71.43% |
| 30 Sep, 14 | 7 | -53.33% |
| 30 Jun, 14 | 15 | 36.36% |
| 31 Mar, 14 | 11 | -8.33% |
| 31 Dec, 13 | 12 | - |
14 institutional shareholders have increased their position in ADMP stock as of 31 Mar 23 compared to 19 in the previous quarter (a -26.32% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 7 | -30.00% |
| 31 Dec, 22 | 10 | - |
| 30 Sep, 22 | 10 | 25.00% |
| 30 Jun, 22 | 8 | -42.86% |
| 31 Mar, 22 | 14 | 75.00% |
| 31 Dec, 21 | 8 | -11.11% |
| 30 Sep, 21 | 9 | 80.00% |
| 30 Jun, 21 | 5 | -16.67% |
| 31 Mar, 21 | 6 | 20.00% |
| 31 Dec, 20 | 5 | -44.44% |
| 30 Sep, 20 | 9 | 50.00% |
| 30 Jun, 20 | 6 | 50.00% |
| 31 Mar, 20 | 4 | -55.56% |
| 31 Dec, 19 | 9 | -18.18% |
| 30 Sep, 19 | 11 | -21.43% |
| 30 Jun, 19 | 14 | 7.69% |
| 31 Mar, 19 | 13 | -23.53% |
| 31 Dec, 18 | 17 | 112.50% |
| 30 Sep, 18 | 8 | -27.27% |
| 30 Jun, 18 | 11 | -21.43% |
| 31 Mar, 18 | 14 | 16.67% |
| 31 Dec, 17 | 12 | -14.29% |
| 30 Sep, 17 | 14 | 250.00% |
| 30 Jun, 17 | 4 | -50.00% |
| 31 Mar, 17 | 8 | 60.00% |
| 31 Dec, 16 | 5 | -16.67% |
| 30 Sep, 16 | 6 | -25.00% |
| 30 Jun, 16 | 8 | -11.11% |
| 31 Mar, 16 | 9 | 80.00% |
| 31 Dec, 15 | 5 | -16.67% |
| 30 Sep, 15 | 6 | -14.29% |
| 30 Jun, 15 | 7 | - |
| 31 Mar, 15 | 7 | 75.00% |
| 31 Dec, 14 | 4 | -55.56% |
| 30 Sep, 14 | 9 | 350.00% |
| 30 Jun, 14 | 2 | -33.33% |
| 31 Mar, 14 | 3 | - |
| 31 Dec, 13 | - | - |
7 institutional shareholders have reduced their position in ADMP stock as of 31 Mar 23 compared to 10 in the previous quarter (a -30.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 47 | -2.08% | 27,578,759 | 116.45% | 18.04% | 25.98% | 14 | -26.32% | 7 | -30.00% |
| 31 Dec, 22 | 48 | 14.29% | 12,741,373 | -0.87% | 8.33% | 11.79% | 19 | 171.43% | 10 | - |
| 30 Sep, 22 | 42 | -10.64% | 12,853,658 | -0.05% | 8.41% | 11.88% | 7 | -46.15% | 10 | 25.00% |
| 30 Jun, 22 | 47 | -4.08% | 12,860,150 | -0.47% | 8.41% | 11.78% | 13 | 30.00% | 8 | -42.86% |
| 31 Mar, 22 | 49 | -15.52% | 12,920,867 | -8.87% | 8.45% | 2.53% | 10 | -52.38% | 14 | 75.00% |
| 31 Dec, 21 | 58 | -3.33% | 14,178,275 | -5.86% | 18.28% | 4.85% | 21 | -4.55% | 8 | -11.11% |
| 30 Sep, 21 | 60 | 7.14% | 15,061,600 | -6.71% | 19.42% | 4.48% | 22 | -24.14% | 9 | 80.00% |
| 30 Jun, 21 | 56 | -5.08% | 16,144,910 | 28.66% | 20.81% | 7.95% | 29 | -9.38% | 5 | -16.67% |
| 31 Mar, 21 | 59 | 59.46% | 12,548,847 | 116.23% | 16.18% | 28.90% | 32 | 128.57% | 6 | 20.00% |
| 31 Dec, 20 | 37 | -19.57% | 5,803,579 | -12.40% | 7.48% | 10.26% | 14 | -26.32% | 5 | -44.44% |
| 30 Sep, 20 | 46 | 12.20% | 6,624,974 | 30.40% | 8.54% | 9.39% | 19 | 26.67% | 9 | 50.00% |
| 30 Jun, 20 | 41 | 2.50% | 5,080,368 | -37.72% | 9.54% | 4.07% | 15 | -11.76% | 6 | 50.00% |
| 31 Mar, 20 | 40 | 11.11% | 8,157,536 | 69.79% | 15.32% | 18.82% | 17 | 21.43% | 4 | -55.56% |
| 31 Dec, 19 | 36 | -21.74% | 4,804,485 | -41.06% | 9.02% | 3.85% | 14 | -17.65% | 9 | -18.18% |
| 30 Sep, 19 | 46 | -13.21% | 8,150,866 | 9.39% | 15.30% | 7.82% | 17 | - | 11 | -21.43% |
| 30 Jun, 19 | 53 | -10.17% | 7,451,029 | -28.51% | 13.99% | 3.65% | 17 | -29.17% | 14 | 7.69% |
| 31 Mar, 19 | 59 | -4.84% | 10,422,782 | 25.22% | 19.57% | 8.01% | 24 | 33.33% | 13 | -23.53% |
| 31 Dec, 18 | 62 | -1.59% | 8,323,796 | -21.33% | 15.63% | 3.96% | 18 | -51.35% | 17 | 112.50% |
| 30 Sep, 18 | 63 | 18.87% | 10,580,850 | 166.97% | 19.86% | 35.88% | 37 | 117.65% | 8 | -27.27% |
| 30 Jun, 18 | 53 | -8.62% | 3,963,338 | 14.32% | 7.44% | 17.56% | 17 | -32.00% | 11 | -21.43% |
| 31 Mar, 18 | 58 | -7.94% | 3,467,010 | -16.84% | 6.51% | 10.62% | 25 | -30.56% | 14 | 16.67% |
| 31 Dec, 17 | 63 | 21.15% | 4,169,135 | -24.88% | 7.83% | 7.21% | 36 | 44.00% | 12 | -14.29% |
| 30 Sep, 17 | 52 | -1.89% | 5,549,795 | 74.42% | 10.42% | 29.20% | 25 | -30.56% | 14 | 250.00% |
| 30 Jun, 17 | 53 | 51.43% | 3,181,891 | 3.06% | 5.97% | 17.78% | 36 | 140.00% | 4 | -50.00% |
| 31 Mar, 17 | 35 | -10.26% | 3,087,536 | 9.53% | 5.80% | 20.70% | 15 | -16.67% | 8 | 60.00% |
| 31 Dec, 16 | 39 | -7.14% | 2,818,843 | -3.40% | 5.29% | 17.63% | 18 | -21.74% | 5 | -16.67% |
| 30 Sep, 16 | 42 | 16.67% | 2,918,058 | 43.75% | 5.48% | 37.72% | 23 | 27.78% | 6 | -25.00% |
| 30 Jun, 16 | 36 | 24.14% | 2,029,888 | -21.98% | 3.81% | 15.97% | 18 | 80.00% | 8 | -11.11% |
| 31 Mar, 16 | 29 | 16.00% | 2,601,772 | -5.64% | 4.88% | 18.23% | 10 | -9.09% | 9 | 80.00% |
| 31 Dec, 15 | 25 | -3.85% | 2,757,389 | -62.74% | 5.18% | 2.68% | 11 | 22.22% | 5 | -16.67% |
| 30 Sep, 15 | 26 | -7.14% | 7,400,974 | 184.20% | 13.89% | 58.13% | 9 | -35.71% | 6 | -14.29% |
| 30 Jun, 15 | 28 | -3.45% | 2,604,122 | 4.66% | 4.89% | 22.40% | 14 | -22.22% | 7 | - |
| 31 Mar, 15 | 29 | 38.10% | 2,488,134 | 30.09% | 4.67% | 36.23% | 18 | 50.00% | 7 | 75.00% |
| 31 Dec, 14 | 21 | - | 1,912,592 | 99.38% | 3.59% | 110.71% | 12 | 71.43% | 4 | -55.56% |
| 30 Sep, 14 | 21 | 5.00% | 959,284 | -18.36% | 1.80% | 37.01% | 7 | -53.33% | 9 | 350.00% |
| 30 Jun, 14 | 20 | 5.26% | 1,174,964 | -29.75% | 2.21% | 22.37% | 15 | 36.36% | 2 | -33.33% |
| 31 Mar, 14 | 19 | 58.33% | 1,672,478 | -17.31% | 3.14% | 21.78% | 11 | -8.33% | 3 | - |
| 31 Dec, 13 | 12 | - | 2,022,521 | - | 3.80% | - | 12 | - | - | - |
Adamis Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Adamis Pharmaceuticals's stock was made by Versi Ebrahim on Sep 19 2023, selling 729 shares at - per share (valued at -).
Adamis Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2022 | 1 | 1 | 100.00% |
| Q2 2022 | 2 | - | - |
| Q1 2022 | - | 4 | - |
| Q4 2021 | 1 | 4 | 25.00% |
| Q2 2021 | - | 5 | - |
| Q1 2021 | 4 | 4 | 100.00% |
| Q4 2020 | - | 7 | - |
| Q3 2020 | - | 7 | - |
| Q2 2020 | - | 5 | - |
| Q1 2020 | - | 15 | - |
| Q4 2019 | - | 6 | - |
| Q3 2019 | 2 | 5 | 40.00% |
| Q2 2019 | 3 | 5 | 60.00% |
| Q1 2019 | 14 | 10 | 140.00% |
| Q4 2018 | - | 1 | - |
| Q3 2018 | 3 | - | - |
| Q1 2018 | 13 | - | - |
| Q4 2017 | - | 1 | - |
| Q2 2017 | 3 | - | - |
| Q1 2017 | 11 | - | - |
1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Adamis Pharmaceuticals's insiders, as of Q4 2022.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 4 | - |
| Q4 2021 | - | 4 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 7 | - |
| Q3 2020 | - | 7 | - |
| Q2 2020 | - | 5 | - |
| Q1 2020 | - | 10 | - |
| Q4 2019 | - | 5 | - |
| Q3 2019 | - | 5 | - |
| Q2 2019 | 3 | 5 | 60.00% |
| Q1 2019 | - | 5 | - |
| Q4 2018 | - | - | - |
| Q3 2018 | - | - | - |
| Q1 2018 | - | - | - |
| Q4 2017 | - | - | - |
| Q2 2017 | - | - | - |
| Q1 2017 | - | - | - |
As of Q4 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Adamis Pharmaceuticals's stocks.
Adamis Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| EVOK | Evoke Pharma, Inc. |
| TLRY | Tilray Brands, Inc. |
| AQST | Aquestive Therapeutics, Inc. |
| LFCR | Lifecore Biomedical, Inc. |
| ORGO | Organogenesis Holdings Inc. |
| GHSI | Guardion Health Sciences, Inc. |
| ALIM | Alimera Sciences, Inc. |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
| ACRX | Talphera, Inc. |
| LSDI | Lucy Scientific Discovery Inc. |
| CTLT | Catalent, Inc. |
ADMP Ownership FAQ
Who Owns Adamis Pharmaceuticals?
Adamis Pharmaceuticals is owned by institutional shareholders (18.04%), insiders (7.81%), and public (74.15%). The largest institutional shareholder of Adamis Pharmaceuticals is BANK OF AMERICA CORP /DE/ (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.21% of total shares).
Who are the major institutional shareholders of Adamis Pharmaceuticals?
Adamis Pharmaceuticals's major institutional shareholders are BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, STATE STREET CORP, and VANGUARD GROUP INC. The top five shareholders own together 0% of the company's share outstanding.
How many Adamis Pharmaceuticals shareholders are there?
As of Mar 2023, there are 47 institutional shareholders of Adamis Pharmaceuticals.
What percentage of Adamis Pharmaceuticals is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ owns 0 shares of Adamis Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).
What percentage of Adamis Pharmaceuticals is owned by WELLS FARGO & COMPANY/MN?
As of Jun 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Adamis Pharmaceuticals (ADMP), compromising 0% of the company, valued at $0.
What percentage of Adamis Pharmaceuticals is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Adamis Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).